Vaxneuvance 4 mcg

VAXNEUVANCE 4 MCG is a pneumococcal polysaccharide vaccine designed to help prevent infections caused by the pneumococcus bacteria. This intramuscular suspension is manufactured by Merck Canada Inc. and is suitable for individuals seeking protection against specific serotypes, including serotype 6B.

VAXNEUVANCE 4 MCG is used to help prevent infections caused by the pneumococcus bacteria. It targets specific serotypes, including serotype 6B, which can cause various illnesses. This vaccine is administered intramuscularly and is intended for individuals who may be at risk of pneumococcal infections.

Common effects of VAXNEUVANCE 4 MCG may include mild redness, swelling, or pain at the injection site. Some individuals might experience temporary fever, fatigue, or muscle aches. These effects are generally mild and short-lived.

VAXNEUVANCE 4 MCG should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to discuss any pre-existing medical conditions or allergies with a healthcare provider before receiving the vaccine.

VAXNEUVANCE 4 MCG may interact with certain medications or other vaccines. It is advisable to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Specific interactions with alcohol or other substances have not been widely reported, but general precautions should be taken.